Literature DB >> 17638662

Correlating routine cytology, quantitative nuclear morphometry by digital image analysis, and genetic alterations by fluorescence in situ hybridization to assess the sensitivity of cytology for detecting pancreatobiliary tract malignancy.

Emily G Barr Fritcher1, Benjamin R Kipp, Jeffrey M Slezak, Laura E Moreno-Luna, Gregory J Gores, Michael J Levy, Lewis R Roberts, Kevin C Halling, Thomas J Sebo.   

Abstract

Routine cytologic (RC), fluorescence in situ hybridization (FISH), digital image analysis (DIA), and quantifiable morphometric results from 284 pancreatobiliary stricture brushings were compared. We chose specific DIA nuclear features assessed by pathologists in evaluating RC specimens, such as area and shape. A visual nuclear morphometric score (VNMS) was calculated. There was a difference (P < .001) in the mean VNMS when RC results were classified as negative (11.5), atypical (12.5), suspicious (13.8), and positive (16.5). The mean VNMS of specimens diagnosed as disomy (11.3), trisomy 7 (12.1), and polysomy (14.7) by FISH was also different (P < .001). There was no difference in the VNMS of false-negative and true-negative cytologic specimens (P = .225). Our findings substantiate the relationship between cell nuclear visual alterations and genetic FISH abnormalities. The low sensitivity of cytologic examination for pancreatobiliary carcinoma is due to an absence of tumor cells or the presence of well-differentiated tumor lacking recognizable nuclear atypia.

Entities:  

Mesh:

Year:  2007        PMID: 17638662     DOI: 10.1309/BC6DY755Q3T5W9EE

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  21 in total

Review 1.  Advanced endoscopic imaging of indeterminate biliary strictures.

Authors:  James H Tabibian; Kavel H Visrodia; Michael J Levy; Christopher J Gostout
Journal:  World J Gastrointest Endosc       Date:  2015-12-10

2.  Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma.

Authors:  Arjun Nanda; Jason M Brown; Stephen H Berger; Melinda M Lewis; Emily G Barr Fritcher; Gregory J Gores; Steven A Keilin; Kevin E Woods; Qiang Cai; Field F Willingham
Journal:  Therap Adv Gastroenterol       Date:  2015-03       Impact factor: 4.409

Review 3.  Liver transplantation in the management of perihilar cholangiocarcinoma.

Authors:  Aliya F Gulamhusein; William Sanchez
Journal:  Hepat Oncol       Date:  2015-11-06

4.  Endoscopic diagnosis of extrahepatic bile duct carcinoma: Advances and current limitations.

Authors:  Kiichi Tamada; Jun Ushio; Kentaro Sugano
Journal:  World J Clin Oncol       Date:  2011-05-10

Review 5.  Current diagnostic and management options in perihilar cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  Digestion       Date:  2014-05-22       Impact factor: 3.216

6.  Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography.

Authors:  Benjamin R Kipp; Emily G Barr Fritcher; Amy C Clayton; Gregory J Gores; Lewis R Roberts; Jun Zhang; Michael J Levy; Kevin C Halling
Journal:  J Mol Diagn       Date:  2010-09-23       Impact factor: 5.568

7.  A new clinically based staging system for perihilar cholangiocarcinoma.

Authors:  Roongruedee Chaiteerakij; William S Harmsen; Carlos Romero Marrero; Mohammed M Aboelsoud; Albert Ndzengue; Joseph Kaiya; Terry M Therneau; William Sanchez; Gregory J Gores; Lewis R Roberts
Journal:  Am J Gastroenterol       Date:  2014-11-11       Impact factor: 10.864

8.  DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease.

Authors:  Mansour A Parsi; Ang Li; Chung-Pin Li; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-05       Impact factor: 11.382

Review 9.  Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era.

Authors:  Håvard E Danielsen; Manohar Pradhan; Marco Novelli
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

Review 10.  Classification, diagnosis, and management of cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-13       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.